Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a condition called CTEPH (chronic thromboembolic pulmonary hypertension), meaning old blood clots are causing high blood pressure in the lungs, confirmed by specific scans (such as a VQ scan, CT scan, or MRI of the lungs)
- Your blood pressure in the lungs is measured at a certain level at rest, or if it is lower than that level, the blood clots are still causing problems with your ability to exercise (confirm with trial site)
- You have been taking blood-thinning medication for at least 3 months before your CTEPH diagnosis
- Doctors have decided that surgery to remove the blood clots (called pulmonary endarterectomy) is not a suitable option for you
- You are willing and able to give your written agreement to take part in the study
Who may not be able to join:
- You are unwilling or unable to give written consent to take part in the study
- It would not be possible for the trial team to check in with you for follow-up appointments during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-010-88396589
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Treatment-Emergent Adverse Events of BPA procedure.; Change of Pulmonary artery pressure in mmHg caused by series of BPA.; Change of Pulmonary vascular resistance (PVR) in Wood U caused by series of BPA.; Change of cardiac index (CI) in L/m^2 caused by series of BPA.; Change of World Health Organization (WHO) functional capacity classification caused by series of BPA.; Change of six minutes walk distance in meter caused by series of BPA.; Change of N-terminal B-type natriuretic peptide in pg/ml caused by series of BPA.; Change of Peak VO2/kg in ml/min/kg caused by series of BPA.;...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.